Search Results

There are 1659 results for: content related to: Effect of renal impairment on the pharmacokinetics of the GLP-1 analogue liraglutide

  1. Glucagon-like peptide analogues for type 2 diabetes mellitus

    Intervention Review

    The Cochrane Library

    Deepson S. Shyangdan, Pamela Royle, Christine Clar, Pawana Sharma, Norman Waugh and Ailsa Snaith

    Published Online : 5 OCT 2011, DOI: 10.1002/14651858.CD006423.pub2

  2. Liraglutide – overview of the preclinical and clinical data and its role in the treatment of type 2 diabetes

    Diabetes, Obesity and Metabolism

    Volume 13, Issue 3, March 2011, Pages: 207–220, M. J. Davies, R. Kela and K. Khunti

    Version of Record online : 24 JAN 2011, DOI: 10.1111/j.1463-1326.2010.01330.x

  3. Liraglutide: A New Option for the Treatment of Obesity

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 35, Issue 10, October 2015, Pages: 926–934, Wesley A. Nuffer and Jennifer M. Trujillo

    Version of Record online : 24 OCT 2015, DOI: 10.1002/phar.1639

  4. Liraglutide: Clinical Pharmacology and Considerations for Therapy

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 31, Issue 9, September 2011, Pages: 896–911, Evan M. Sisson

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.31.9.896

  5. Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 1, January 2013, Pages: 42–54, K. Niswender, X. Pi-Sunyer, J. Buse, K. H. Jensen, A. D. Toft, D. Russell-Jones and B. Zinman

    Version of Record online : 9 SEP 2012, DOI: 10.1111/j.1463-1326.2012.01673.x

  6. Clinical Studies of Liraglutide, a Novel, Once-Daily Human Glucagon-Like Peptide-1 Analog for Improved Management of Type 2 Diabetes Mellitus

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 12P2, December 2009, Pages: 43S–54S, Scott R. Drab

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.29.pt2.43S

  7. The Pharmacokinetics, Pharmacodynamics, and Tolerability of Liraglutide, a Once-Daily Human GLP-1 Analogue, After Multiple Subcutaneous Administration in Healthy Chinese Male Subjects

    The Journal of Clinical Pharmacology

    Volume 51, Issue 12, December 2011, Pages: 1620–1627, Dr Ji Jiang, Ms Jianyan Zhang, Ms Lisbeth V. Jacobsen and Dr Pei Hu

    Version of Record online : 12 MAR 2013, DOI: 10.1177/0091270010389468

  8. Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 3, March 2013, Pages: 204–212, M. Nauck, A. Frid, K. Hermansen, A. B. Thomsen, M. During, N. Shah, T. Tankova, I. Mitha and D. R. Matthews

    Version of Record online : 11 OCT 2012, DOI: 10.1111/dom.12012

  9. You have free access to this content
    Comparative Effects of the Long-Acting GLP-1 Receptor Ligands, Liraglutide and Exendin-4, on Food Intake and Body Weight Suppression in Rats

    Obesity

    Volume 19, Issue 7, July 2011, Pages: 1342–1349, Matthew R. Hayes, Scott E. Kanoski, Amber L. Alhadeff and Harvey J. Grill

    Version of Record online : 10 SEP 2012, DOI: 10.1038/oby.2011.50

  10. You have free access to this content
    Liraglutide: the therapeutic promise from animal models

    International Journal of Clinical Practice

    Volume 64, Issue s167, October 2010, Pages: 4–11, L. B. Knudsen

    Version of Record online : 23 SEP 2010, DOI: 10.1111/j.1742-1241.2010.02499.x

  11. You have full text access to this OnlineOpen article
    Liraglutide: from clinical trials to clinical practice

    Diabetes, Obesity and Metabolism

    Volume 14, Issue s2, April 2012, Pages: 33–40, S. C. L. Gough

    Version of Record online : 8 MAR 2012, DOI: 10.1111/j.1463-1326.2012.01576.x

  12. You have free access to this content
    The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1–5 studies

    Diabetes, Obesity and Metabolism

    Volume 11, Issue s3, December 2009, Pages: 26–34, L. Blonde and D. Russell-Jones

    Version of Record online : 29 OCT 2009, DOI: 10.1111/j.1463-1326.2009.01075.x

  13. You have full text access to this Open Access content
    Fifty-two-week, randomized, multicenter trial to compare the safety and efficacy of the novel glucagon-like peptide-1 analog liraglutide vs glibenclamide in patients with type 2 diabetes

    Journal of Diabetes Investigation

    Volume 2, Issue 6, December 2011, Pages: 441–447, Kohei Kaku, Mads Frederik Rasmussen, Tomoyuki Nishida and Yutaka Seino

    Version of Record online : 19 MAY 2011, DOI: 10.1111/j.2040-1124.2011.00128.x

  14. You have full text access to this OnlineOpen article
    Comparison of liraglutide versus other incretin-related anti-hyperglycaemic agents

    Diabetes, Obesity and Metabolism

    Volume 14, Issue s2, April 2012, Pages: 20–32, L. Blonde and E. Montanya

    Version of Record online : 8 MAR 2012, DOI: 10.1111/j.1463-1326.2012.01575.x

  15. Liraglutide provides similar glycaemic control as glimepiride (both in combination with metformin) and reduces body weight and systolic blood pressure in Asian population with type 2 diabetes from China, South Korea and India: a 16-week, randomized, double-blind, active control trial

    Diabetes, Obesity and Metabolism

    Volume 13, Issue 1, January 2011, Pages: 81–88, W. Yang, L. Chen, Q. Ji, X. Liu, J. Ma, N. Tandon, A. Bhattacharyya, A. Kumar, K.-W. Kim, K.-H. Yoon, O. M. Bech and M. Zychma

    Version of Record online : 28 NOV 2010, DOI: 10.1111/j.1463-1326.2010.01323.x

  16. You have free access to this content
    The extra-pancreatic effects of GLP-1 receptor agonists: a focus on the cardiovascular, gastrointestinal and central nervous systems

    Diabetes, Obesity and Metabolism

    Volume 16, Issue 8, August 2014, Pages: 673–688, J. Seufert and B. Gallwitz

    Version of Record online : 16 JAN 2014, DOI: 10.1111/dom.12251

  17. You have full text access to this OnlineOpen article
    The glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents

    Addiction Biology

    Volume 21, Issue 2, March 2016, Pages: 422–437, Daniel Vallöf, Paola Maccioni, Giancarlo Colombo, Minja Mandrapa, Julia Winsa Jörnulf, Emil Egecioglu, Jörgen A. Engel and Elisabet Jerlhag

    Version of Record online : 25 AUG 2015, DOI: 10.1111/adb.12295

  18. You have full text access to this OnlineOpen article
    Cost–utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type 2 diabetes mellitus

    Diabetic Medicine

    Volume 29, Issue 3, March 2012, Pages: 313–320, M. J. Davies, B. D. Chubb, I. C. Smith and W. J. Valentine

    Version of Record online : 22 FEB 2012, DOI: 10.1111/j.1464-5491.2011.03429.x

  19. You have full text access to this OnlineOpen article
    Liraglutide in oral antidiabetic drug combination therapy

    Diabetes, Obesity and Metabolism

    Volume 14, Issue s2, April 2012, Pages: 13–19, A. J. Garber

    Version of Record online : 8 MAR 2012, DOI: 10.1111/j.1463-1326.2012.01574.x

  20. Co-administration of liraglutide with insulin detemir demonstrates additive pharmacodynamic effects with no pharmacokinetic interaction

    Diabetes, Obesity and Metabolism

    Volume 13, Issue 1, January 2011, Pages: 75–80, L. Morrow, M. Hompesch, H. Guthrie, D. Chang and D. J. Chatterjee

    Version of Record online : 28 NOV 2010, DOI: 10.1111/j.1463-1326.2010.01322.x